Condition: Pancreatic carcinoma 
rs505922 in 
ABO gene and 
Pancreatic carcinoma
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 19648918 2009 We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28).
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
 
rs10983614 in 
ASTN2 gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs372883 in 
BACH1 gene and 
Pancreatic carcinoma
PMID 22158540 2011 Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.
 
rs7190458 in 
BCAR1 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
 
rs708224 in 
BICD1 gene and 
Pancreatic carcinoma
PMID 20686608 2010 Genome-wide association study of pancreatic cancer in Japanese population.
 
rs1182933 in 
C12orf43 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
 
rs2255280 in 
C9;DAB2 gene and 
Pancreatic carcinoma
PMID 22158540 2011 Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.
 
rs10094872 in 
CASC11 gene and 
Pancreatic carcinoma
PMID 27579533 2016 This analysis, in combination with a two-staged replication in an additional 6,076 case and 7,555 control subjects from the PANcreatic Disease ReseArch (PANDoRA) and Pancreatic Cancer Case-Control (PanC4) Consortia uncovered 3 new pancreatic cancer risk signals marked by single nucleotide polymorphisms (SNPs) rs2816938 at chromosome 1q32.1 (per allele odds ratio (OR) = 1.20, P = 4.88x10 -15), rs10094872 at 8q24.21 (OR = 1.15, P = 3.22x10 -9) and rs35226131 at 5p15.33 (OR = 0.71, P = 1.70x10 -8).
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
 
rs31490 in 
CLPTM1L gene and 
Pancreatic carcinoma
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
PMID 20101243 2010 A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
 
rs11141915 in 
DAPK1 gene and 
Pancreatic carcinoma
PMID 22293537 2012 A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.
 
rs6464375 in 
DPP6 gene and 
Pancreatic carcinoma
PMID 20686608 2010 Genome-wide association study of pancreatic cancer in Japanese population.
 
rs12620038 in 
EPCAM-DT gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs6662005 in 
ERO1B gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs1169296 in 
HNF1A gene and 
Pancreatic carcinoma
PMID 30541042 2019 Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs12951345 in 
HNF1B;LOC105371754 gene and 
Pancreatic carcinoma
PMID 30541042 2019 Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
PMID 29422604 2018 Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10<sup>-14</sup>), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10<sup>-10</sup>), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10<sup>-8</sup>), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10<sup>-8</sup>). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA.
 
rs2941471 in 
HNF4G gene and 
Pancreatic carcinoma
PMID 29422604 2018 Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10<sup>-14</sup>), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10<sup>-10</sup>), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10<sup>-8</sup>), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10<sup>-8</sup>). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA.
 
rs16861827 in 
IGSF21 gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs763780 in 
IL17F gene and 
Pancreatic carcinoma
PMID 22142827 2012 A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs361052 in 
IQSEC1 gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs13303010 in 
KLHL17;NOC2L gene and 
Pancreatic carcinoma
PMID 29422604 2018 Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10<sup>-14</sup>), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10<sup>-10</sup>), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10<sup>-8</sup>), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10<sup>-8</sup>). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA.
 
rs12456874 in 
LDLRAD4 gene and 
Pancreatic carcinoma
PMID 23180869 2014 Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs10835188 in 
LIN7C gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs6971499 in 
LINC-PINT gene and 
Pancreatic carcinoma
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
 
rs11655237 in 
LINC00511;LINC00673 gene and 
Pancreatic carcinoma
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs7214041 in 
LINC00673;LINC00511 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
 
rs1561927 in 
LINC00824 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
 
rs6073450 in 
LINC01620 gene and 
Pancreatic carcinoma
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs962856 in 
LINC01829 gene and 
Pancreatic carcinoma
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs9554197 in 
LOC105370130;PLUT gene and 
Pancreatic carcinoma
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs1547374 in 
LOC105372815 gene and 
Pancreatic carcinoma
PMID 22158540 2011 Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.
 
rs1326889 in 
LOC105373166 gene and 
Pancreatic carcinoma
PMID 30541042 2019 Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
 
rs4269383 in 
LOC105378072;LOC101928923 gene and 
Pancreatic carcinoma
PMID 22158540 2011 Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.
 
rs450960 in 
MICAL3 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
 
rs3790844 in 
NR5A2 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 20101243 2010 A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
 
rs9581943 in 
PDX1 gene and 
Pancreatic carcinoma
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
 
rs876493 in 
PNMT gene and 
Pancreatic carcinoma
PMID 30541042 2019 Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
 
rs2900174 in 
PRB2;PRB1 gene and 
Pancreatic carcinoma
PMID 22142827 2012 A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs10500715 in 
SBF2 gene and 
Pancreatic carcinoma
PMID 23180869 2014 Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
 
rs12362504 in 
SBF2;LOC101928008 gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs2417487 in 
SMC2 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 30541042 2019 Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
 
rs17688601 in 
SUGCT;LOC112267984 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs5768709 in 
TAFA5 gene and 
Pancreatic carcinoma
PMID 22158540 2011 Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.
 
rs2736098 in 
TERT gene and 
Pancreatic carcinoma
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 27579533 2016 This analysis, in combination with a two-staged replication in an additional 6,076 case and 7,555 control subjects from the PANcreatic Disease ReseArch (PANDoRA) and Pancreatic Cancer Case-Control (PanC4) Consortia uncovered 3 new pancreatic cancer risk signals marked by single nucleotide polymorphisms (SNPs) rs2816938 at chromosome 1q32.1 (per allele odds ratio (OR) = 1.20, P = 4.88x10 -15), rs10094872 at 8q24.21 (OR = 1.15, P = 3.22x10 -9) and rs35226131 at 5p15.33 (OR = 0.71, P = 1.70x10 -8).
 
rs4927850 in 
TFRC gene and 
Pancreatic carcinoma
PMID 22158540 2011 Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.
 
rs73328514 in 
TNS3 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
 
rs77038344 in 
TNS4 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
 
rs9854771 in 
TP63 gene and 
Pancreatic carcinoma
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs351365 in 
WNT2B gene and 
Pancreatic carcinoma
PMID 26098869 2015 Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
 
rs4285214 in 
ZNF608 gene and 
Pancreatic carcinoma
PMID 28470677 2017 Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
 
rs16986825 in 
ZNRF3 gene and 
Pancreatic carcinoma
PMID 25086665 2014 Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
PMID 29422604 2018 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.